stars 1 stars 2 stars 3

Since 1999, ACONITUM has been creating pharmaceutical solutions where science meets the power of nature. As one of Lithuania’s pharmaceutical leaders, the company develops herbal medicines, food supplements and biomedical preparations through a complete in-house process — from concept and formulation to manufacturing and final product. Driven by innovation, ACONITUM creates original formulations rather than copying market solutions, often bringing forward ideas that later become global health trends — from longevity to epigenetic wellness. For B2B partners, the company offers trusted product development, contract manufacturing, CTD dossier support and high-quality production backed by GMP, HACCP and HALAL standards.

Aconitum Questions

The Aconitum annual revenue was $19.5 million in 2026.

Tomas Jokubauskas is the CFO of Aconitum.

29 people are employed at Aconitum.

Aconitum is based in Fez, Kaunas district.

The NAICS codes for Aconitum are [325, 3254, 32, 32541].

The SIC codes for Aconitum are [2834, 28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users